RecA/LexA-dependent SOS response controls the expression of ExPEC endolysin genes. by Min Jiang (56794)

Data_Sheet_1_Cerebral Oxygenation and Activity During Surgical Repair of Neonates With Congenital Diaphragmatic Hernia: A Center Comparison Analysis.PDF by Sophie A. Costerus (10338170)

“…In the first 30 min of the surgical procedure, a 3-fold increase in fast delta (10.48–31.22 μV²) and a 5-fold increase in gamma (1.42–7.58 μV²) were observed in the midazolam group.…”

Table 1_Association between sarcopenia and outcomes of surgically treated oral squamous cell carcinoma: a systematic review and meta‐analysis.docx by Kai Luo (769190)

“…The development of sarcopenia is mainly attributed to aging, inactivity, poor nutrition, and decreased testosterone levels, which suggest a poor prognosis after surgery. …”

Data_Sheet_1_Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients.xlsx by Shanshan Mei (8432559)

“…In addition, FPG (0.05 ± 0.38 mmol/mL vs -0.50 ± 1.01 mmol/mL, P < 0.001), FINS (−4.88 ± 6.11 μU/mL vs −8.53 ± 5.61 μU/mL, P < 0.01), HOMA-IR index (−1.11 ± 1.51 vs −2.23 ± 0.25, P < 0.05), and QUIKI index (0.014 ± 0.016 vs 0.028 ± 0.019, P < 0.05) decreased significantly in the MED/LC group compared with the LF group. …”

Data_Sheet_2_Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients.xlsx by Shanshan Mei (8432559)

“…In addition, FPG (0.05 ± 0.38 mmol/mL vs -0.50 ± 1.01 mmol/mL, P < 0.001), FINS (−4.88 ± 6.11 μU/mL vs −8.53 ± 5.61 μU/mL, P < 0.01), HOMA-IR index (−1.11 ± 1.51 vs −2.23 ± 0.25, P < 0.05), and QUIKI index (0.014 ± 0.016 vs 0.028 ± 0.019, P < 0.05) decreased significantly in the MED/LC group compared with the LF group. …”

Table 1_Loneliness and mental burden among German medical students during the fading COVID-19 pandemic: a mixed-methods approach.docx by Marvik Leich (20930363)

“…In winter 2021/22, 55.1% of students reported loneliness above the cut-off (M = 5.77 [2.02]; decreasing to 45.0% by summer 2022 (M = 5.22 [1.90]). …”

Detection of membrane and cytoplasmic proteins in density gradient ultracentrifugation (DGU)-purified ExPEC EVs. by Min Jiang (56794)

An Antifatigue Liquid Metal Composite Electrode Ionic Polymer-Metal Composite Artificial Muscle with Excellent Electromechanical Properties by Zhihao He (6439043)

“…It turns out that the prepared EGaIn/Pt-IPMC exhibits a driving force up to 120 mN and maximum fatigue life of about 25,000 s at a driving voltage of 3 V. …”

An Antifatigue Liquid Metal Composite Electrode Ionic Polymer-Metal Composite Artificial Muscle with Excellent Electromechanical Properties by Zhihao He (6439043)

“…It turns out that the prepared EGaIn/Pt-IPMC exhibits a driving force up to 120 mN and maximum fatigue life of about 25,000 s at a driving voltage of 3 V. …”

An Antifatigue Liquid Metal Composite Electrode Ionic Polymer-Metal Composite Artificial Muscle with Excellent Electromechanical Properties by Zhihao He (6439043)

“…It turns out that the prepared EGaIn/Pt-IPMC exhibits a driving force up to 120 mN and maximum fatigue life of about 25,000 s at a driving voltage of 3 V. …”

An Antifatigue Liquid Metal Composite Electrode Ionic Polymer-Metal Composite Artificial Muscle with Excellent Electromechanical Properties by Zhihao He (6439043)

“…It turns out that the prepared EGaIn/Pt-IPMC exhibits a driving force up to 120 mN and maximum fatigue life of about 25,000 s at a driving voltage of 3 V. …”

Molecular mass of peak samples of HWHF by LC-MS analysis. by Prawej Ansari (12191266)

Effect of chronic statin treatment (10mg/kg p.o.) on trial latency in simple discrimination (A) and reversal tasks (B) in normal rats. by Sarah A. Stuart (456773)

Supplementary tables: Assessing healthcare resource utilization burden and unmet treatment needs in patients with Parkinson’s disease: results from a real-world study by Malgorzata Ciepielewska (22143499)

“…Patients were staged as early (Hoehn and Yahr stage 1–2), intermediate (stage 2.5–3) or severe (stage 4–5) PD. Analyses compared PD stages, focusing on the intermediate group. …”

Supplementary data: Assessing healthcare resource utilization burden and unmet treatment needs in patients with Parkinson’s disease: results from a real-world study by Malgorzata Ciepielewska (22143499)

“…Patients were staged as early (Hoehn and Yahr stage 1–2), intermediate (stage 2.5–3) or severe (stage 4–5) PD. Analyses compared PD stages, focusing on the intermediate group. …”

A single i.p. dose of neuron-binding antibody (rHIgM12) improves horizontal activity in chronically infected SJL mice. by Aleksandar Denic (342052)

“…After the treatment mice were monitored continuously over 8 weeks. Panels A, C and E correspond to horizontal activity and B, D and F correspond to vertical activity. …”

<b>Metabolic Perturbations and Ectopic Fat Deposition in Low Birthweight Subjects</b><b>– Effects of a 4 Week Carbohydrate Overfeeding Challenge</b> by Charlotte Brøns (261017)

“…<p dir="ltr">Low birthweight (LBW) is a risk factor for type-2 diabetes (T2D). We hypothesized that 4-weeks carbohydrate overfeeding (COF) with +25% energy would unmask key T2D perturbations among 22 non-obese LBW men, including 5 with screen-detected metabolic dysfunction–associated steatotic liver disease (MASLD), compared with 21 healthy normal birthweight (NBW) controls. …”

Additional file 4 of Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma by Yan-Lin Wen (10982707)

“…Upstream mechanisms of action of TACC3 overexpression in cervical cancer. (A) Genetic alterations were detected in approximately 5% of patients withcervical cancer from The Cancer Genome Atlas (TCGA) cohort (n = 270), and tumors with mutations were extremely rare. …”

Supplementary Material for: Albumin and platelet loss during the application of CytoSorb® in critically ill patients: a post-hoc analysis of the Cyto-SOLVE trial by Brozat C.I. (20130933)

Image1_Effectiveness of medication self-management, self-monitoring and a lifestyle intervention on hypertension in poorly controlled patients: The MEDICHY randomized trial.tif by Fabián Unda Villafuerte (18589192)

“…After 6 months, the intervention group had a significantly lower systolic blood pressure (135.1 mmHg [±14.8] vs. 142.7 mmHg [±15.0], adjusted mean difference: 8.7 mmHg [95% CI: 3.4, 13.9], p < 0.001) and a significantly lower diastolic blood pressure (83.5 mmHg [±8.8] vs. 87.00 mmHg [±9.0], adjusted mean difference: 5.4 [95% CI: 2.9, 7.8], p < 0.0001). …”